CN Patent

CN102079772A — 一类五环三萜-13,28-内酯化合物、其制备方法和用途

Assigned to China Pharmaceutical University · Expires 2011-06-01 · 15y expired

What this patent protects

本发明公开了具有抗肿瘤活性的通式I所示的五环三萜-13，28-内酯或其药学上可接受的盐、其制备方法和医药用途，属于生物医药领域。本发明化合物的制备方法不仅反应条件温和，而且操作简单，收率较高，同时还具有很强的实用性和结构普适性。药理实验结果表明，本发明化合物具有优良的抗肿瘤活性，临床上可作为抗肿瘤药物应用。

USPTO Abstract

本发明公开了具有抗肿瘤活性的通式I所示的五环三萜-13，28-内酯或其药学上可接受的盐、其制备方法和医药用途，属于生物医药领域。本发明化合物的制备方法不仅反应条件温和，而且操作简单，收率较高，同时还具有很强的实用性和结构普适性。药理实验结果表明，本发明化合物具有优良的抗肿瘤活性，临床上可作为抗肿瘤药物应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102079772A
Jurisdiction
CN
Classification
—
Expires
2011-06-01
Drug substance claim
No
Drug product claim
No
Assignee
China Pharmaceutical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.